EU approvals for olmesartan/amlodipine combo
This article was originally published in Scrip
Daiichi Sankyohas received approvals in Europe for Sevikar, a fixed-dose, single-pill combination of olmesartan and amlodipine. The once-daily therapy was filed in 28 EU countries in September 2007 and has been approved in Germany, the Netherlands, Spain, France, the UK and Belgium. Other markets are expected to follow soon.